{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:02:13Z","timestamp":1789524133005,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Robotic Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The surgical management of pathologic T3a (pT3a) renal cell carcinoma (RCC) remains contentious due to the lack of high-level evidence guiding the choice between partial nephrectomy (PN) and radical nephrectomy (RN). This systematic review and meta-analysis aims to evaluate whether PN represents a safe and effective alternative to RN. A comprehensive search of PubMed, Web of Science, and Scopus was conducted through July 2025. The study included comparative trials of adult pT3a RCC patients undergoing PN or RN, focusing on oncological, perioperative, and functional outcomes. Sixteen retrospective studies involving 34,304 patients (5878 PN; 28426 RN) were analyzed. There were no statistically significant differences between PN and RN regarding estimated blood loss, operative time, hospital stay, or major postoperative complications (Clavien-Dindo\u2009&gt;\u20092). PN was associated with significantly better preservation of renal function (9.96; I\n                    <jats:sup>2<\/jats:sup>\n                    0%;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01), higher rate of positive surgical margins (0.82; I\n                    <jats:sup>2<\/jats:sup>\n                    49.2%;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01), lower tumor size (-2.6; I\n                    <jats:sup>2<\/jats:sup>\n                    99.4%;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01). PN is a safe and feasible alternative for pT3a RCC cases, providing superior functional preservation without compromising perioperative safety or oncological control.\n                  <\/jats:p>","DOI":"10.1007\/s11701-026-03384-8","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T02:26:50Z","timestamp":1776738410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Partial versus radical nephrectomy for pT3a renal cell carcinoma: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"20","author":[{"given":"Filippo","family":"Gavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Fettucciari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pallotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Carerj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Cavarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Sanesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Pio","family":"Bizzarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Montesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Assumma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Panio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Ragonese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazario","family":"Foschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Turri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Sighinolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"1","key":"3384_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Miller KD, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74(1):12\u201349","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"3384_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.eururo.2010.12.013","volume":"59","author":"H Van Poppel","year":"2011","unstructured":"Van Poppel H, Da Pozzo L, Albrecht W et al (2011) A prospective, randomized EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 59(4):543\u2013552","journal-title":"Eur Urol"},{"issue":"5","key":"3384_CR3","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.eururo.2012.02.039","volume":"61","author":"S MacLennan","year":"2012","unstructured":"MacLennan S, Imamura M, Lapitan MC et al (2012) Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol 61(5):972\u2013993","journal-title":"Eur Urol"},{"issue":"6","key":"3384_CR4","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471\u20131474","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"3384_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.eururo.2016.08.060","volume":"71","author":"MC Mir","year":"2017","unstructured":"Mir MC, Derweesh I, Porpiglia F et al (2017) Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 71(4):606\u2013617","journal-title":"Eur Urol"},{"issue":"4","key":"3384_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","volume":"82","author":"B Ljungberg","year":"2022","unstructured":"Ljungberg B, Albiges L, Abu-Ghanem Y et al (2022) European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol 82(4):399\u2013410","journal-title":"Eur Urol"},{"issue":"6","key":"3384_CR7","first-page":"1444","volume":"199","author":"JK Kim","year":"2018","unstructured":"Kim JK, Kim SI, Ahn HK et al (2018) Motion to Dismiss the Case for Partial Nephrectomy in pT3a Renal Cell Carcinoma: A Propensity Score-Matched Analysis. J Urol 199(6):1444\u20131450","journal-title":"J Urol"},{"issue":"16","key":"3384_CR8","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1002\/cncr.28141","volume":"119","author":"B Shuch","year":"2013","unstructured":"Shuch B, Hanley J, Lai J et al (2013) Overall survival advantage with partial nephrectomy: a bias of observational data? Cancer 119(16):2981\u20132989","journal-title":"Cancer"},{"issue":"5","key":"3384_CR9","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.urology.2012.11.067","volume":"81","author":"MA Gorin","year":"2013","unstructured":"Gorin MA, Mullins JK, Pierorazio PM et al (2013) Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors. Urology 81(5):1015\u20131020","journal-title":"Urology"},{"issue":"4 Pt 1","key":"3384_CR10","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/01.ju.0000173942.19990.40","volume":"174","author":"RH Thompson","year":"2005","unstructured":"Thompson RH, Leibovich BC, Cheville JC et al (2005) Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? J Urol 174(4 Pt 1):1218\u20131221","journal-title":"J Urol"},{"issue":"11","key":"3384_CR11","doi-asserted-by":"publisher","first-page":"e0166183","DOI":"10.1371\/journal.pone.0166183","volume":"11","author":"SH Jeong","year":"2016","unstructured":"Jeong SH, Kim JK, Park J, Jeon HJ, Yoon MY, Jeong CW, Ku JH, Kim HH, Kwak C (2016) Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging. PLoS ONE 11(11):e0166183. https:\/\/doi.org\/10.1371\/journal.pone.0166183PMID: 27861519; PMCID: PMC5115709","journal-title":"PLoS ONE"},{"issue":"4","key":"3384_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.15586\/jkcvhl.v10i4.290","volume":"10","author":"A Alasker","year":"2023","unstructured":"Alasker A, Alnafisah TR, Alghafees M, Shafqat A, Sabbah BN, Alhaider A, Alsayyari A, Althonayan N, AlOtaibi M, Ofisan SB, Alghamdi M, Albogami N, Al-Khayal A (2023) Preserving Renal Function without Compromising Oncological Outcomes: A Comparative Study of Partial and Total Nephrectomies in T3 Stage Renal Cell Carcinoma. J Kidney Cancer VHL 10(4):28\u201332. https:\/\/doi.org\/10.15586\/jkcvhl.v10i4.290PMID: 38162464; PMCID: PMC10755761","journal-title":"J Kidney Cancer VHL"},{"key":"3384_CR13","doi-asserted-by":"publisher","unstructured":"Alvim R, Tin A, Nogueira L, Lebdai S, Wong N, Takeda T, Assel M, Hakimi AA, Touijer K, Russo P, Coleman J A (2021) comparison of oncologic and functional outcomes in patients with pt3a renal cell carcinoma treated with partial and radical nephrectomy. Int Braz J Urol 47(4):777\u2013783. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2020.0149. PMID: 33848068; PMCID: PMC8321499","DOI":"10.1590\/S1677-5538.IBJU.2020.0149"},{"key":"3384_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.urology.2019.11.036","volume":"138","author":"ZA Hamilton","year":"2020","unstructured":"Hamilton ZA, Capitanio U, Pruthi D, Ghali F, Larcher A, Patel DN, Eldefrawy A, Patel S, Cotta BH, Bradshaw AW, Meagher MF, Miller NS, Carenzi C, Wan F, Liss MA, McGregor T, Montorsi F, Derweesh IH (2020) Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria. Urology 138:60\u201368 Epub 2019 Dec 11. PMID: 31836465","journal-title":"Urology"},{"issue":"2","key":"3384_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.urology.2012.04.043","volume":"80","author":"J Hansen","year":"2012","unstructured":"Hansen J, Sun M, Bianchi M, Rink M, Tian Z, Hanna N, Meskawi M, Schmitges J, Shariat SF, Chun FK, Perrotte P, Graefen M, Karakiewicz PI (2012) Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy. Urology 80(2):347\u2013353. https:\/\/doi.org\/10.1016\/j.urology.2012.04.043Epub 2012 Jun 13. PMID: 22698478","journal-title":"Urology"},{"issue":"24","key":"3384_CR16","doi-asserted-by":"publisher","first-page":"8909","DOI":"10.1002\/cam4.4412","volume":"10","author":"S Liu","year":"2021","unstructured":"Liu S, Feng C, Liu C, Wang Z (2021) Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma\u2009\u2264\u20097\u00a0cm T3aN0\/xM0: Survival benefit is biased toward partial nephrectomy. Cancer Med 10(24):8909\u20138923. https:\/\/doi.org\/10.1002\/cam4.4412Epub 2021 Nov 14. PMID: 34779154; PMCID: PMC8683550","journal-title":"Cancer Med"},{"key":"3384_CR17","doi-asserted-by":"crossref","unstructured":"Liu Z, Yang Z, Li J, Liu Z, Ma N, Chen P, Bi X, Li Z, Dong P, Han H, He X, Mao X, Guo S (2023) Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis. Asian J Surg. ;46(9):3607\u20133613. doi: 10.1016\/j.asjsur.2023.04.058. Epub 2023 May 3. PMID: 37147255","DOI":"10.1016\/j.asjsur.2023.04.058"},{"key":"3384_CR18","doi-asserted-by":"publisher","unstructured":"M\u00fchlbauer J, Kowalewski KF, Walach MT, Porubsky S, Wessels F, Nuhn P, Wagener N, Kriegmair MC (2020) Partial nephrectomy preserves renal function without increasing the risk of complications compared with radical nephrectomy for renal cell carcinomas of stages pT2-3a. Int J Urol. ;27(10):906\u2013913. https:\/\/doi.org\/10.1111\/iju.14326. Epub 2020 Aug 11. PMID: 32783245","DOI":"10.1111\/iju.14326"},{"key":"3384_CR19","doi-asserted-by":"publisher","unstructured":"Patel SH, Uzzo RG, Larcher A, Peyronnet B, Lane BR, Pruthi D, Reddy M, Capitanio U, Joshi S, Noyes S, Eldefrawy A, Ghali F, Meagher MF, Hamilton ZA, Yim K, Nasseri R, Bradshaw AW, Dey S, Kirmiz S, Wan F, Liss MA, Bensalah K, Montorsi F, Derweesh IH (2020) Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis. Clin Genitourin Cancer. ;18(6):e723-e729. https:\/\/doi.org\/10.1016\/j.clgc.2020.05.002. Epub 2020 May 11. PMID: 32600941","DOI":"10.1016\/j.clgc.2020.05.002"},{"key":"3384_CR20","doi-asserted-by":"publisher","unstructured":"Pecoraro A, Amparore D, Manfredi M, Piramide F, Checcucci E, Tian Z, Peretti D, Fiori C, Karakiewicz PI, Porpiglia F (2022) Partial vs. radical nephrectomy in non-metastatic pT3a kidney cancer patients: a population-based study. Minerva Urol Nephrol. ;74(4):445\u2013451. https:\/\/doi.org\/10.23736\/S2724-6051.22.04680-8. Epub 2022 Feb 11. PMID: 35147387","DOI":"10.23736\/S2724-6051.22.04680-8"},{"issue":"3","key":"3384_CR21","doi-asserted-by":"publisher","first-page":"102343","DOI":"10.1016\/j.clgc.2025.102343","volume":"23","author":"C Saitta","year":"2025","unstructured":"Saitta C, Autorino R, Capitanio U, Lughezzani G, Meagher MF, Yim K, Nguyen MV, Mantovani M, Guer M, Amparore D, Piramide F, Hakimi K, Patil D, Tanaka H, Fukuda S, Kobayashi M, Chen W, Pandolfo SD, Cortes J, Puri D, Yuen K, Lazzeri M, Fasulo V, Larcher A, Paciotti M, Garofano G, Porpiglia F, Montorsi F, Fujii Y, Master V, Buffi NM, Derweesh IH (2025) Propensity Score-Matched Analysis of Radical and Partial Nephrectomy in pT3aN0M0 Renal Cell Carcinoma. Clin Genitourin Cancer 23(3):102343. https:\/\/doi.org\/10.1016\/j.clgc.2025.102343Epub 2025 Apr 4. PMID: 40286515","journal-title":"Clin Genitourin Cancer"},{"issue":"9","key":"3384_CR22","doi-asserted-by":"publisher","first-page":"e5781","DOI":"10.7759\/cureus.5781","volume":"11","author":"BK Ziegelmueller","year":"2019","unstructured":"Ziegelmueller BK, Spek A, Szabados B, Casuscelli J, Buchner A, Stief C, Staehler M (2019) Partial Nephrectomy in pT3a Tumors Less Than 7\u00a0cm in Diameter Has a Superior Overall Survival Compared to Radical Nephrectomy. Cureus 11(9):e5781. https:\/\/doi.org\/10.7759\/cureus.5781PMID: 31723540; PMCID: PMC6825485","journal-title":"Cureus"},{"issue":"5","key":"3384_CR23","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.urology.2010.11.058","volume":"77","author":"CJ Weight","year":"2011","unstructured":"Weight CJ, Lythgoe C, Unnikrishnan R, Lane BR, Campbell SC, Fergany AF (2011) Partial nephrectomy does not compromise survival in patients with pathologic upstaging to pT2\/pT3 or high-grade renal tumors compared with radical nephrectomy. Urology 77(5):1142\u20131146 Epub 2011 Mar 21. PMID: 21420154","journal-title":"Urology"},{"key":"3384_CR24","doi-asserted-by":"publisher","first-page":"819098","DOI":"10.3389\/fonc.2021.819098","volume":"11","author":"J Tian","year":"2022","unstructured":"Tian J, Zeng X, Wan J, Gan J, Ke C, Guan W, Hu Z, Yang C (2022) Partial and Radical Nephrectomy Provides Equivalent Oncologic Outcomes in pT3a Renal Cell Carcinoma: A Population-Based Study. Front Oncol 11:819098 PMID: 35155208; PMCID: PMC8826755","journal-title":"Front Oncol"},{"key":"3384_CR25","doi-asserted-by":"publisher","unstructured":"Andrade HS, Zargar H, Akca O, Kara O, Caputo PA, Ramirez D, Andr\u00e9s G, Stein RJ, Chueh SJ, Kaouk JH (2017) Is Robotic Partial Nephrectomy Safe for T3a Renal Cell Carcinoma? Experience of a High-Volume Center. J Endourol. ;31(2):153\u2013157. https:\/\/doi.org\/10.1089\/end.2016.0622. Epub 2017 Jan 5. PMID: 27881027","DOI":"10.1089\/end.2016.0622"},{"key":"3384_CR26","doi-asserted-by":"publisher","unstructured":"Patel P, Nayak JG, Liu Z, Saarela O, Jewett M, Rendon R, Kapoor A, Black P, Tanguay S, Kawakami J, Moore R, Breau RH, Morash C, Pouliot F, Drachenberg DE (2017) A Multicentered, Propensity Matched Analysis Comparing Laparoscopic and Open Surgery for pT3a Renal Cell Carcinoma. J Endourol. ;31(7):645\u2013650. https:\/\/doi.org\/10.1089\/end.2016.0787. PMID: 28381117","DOI":"10.1089\/end.2016.0787"},{"key":"3384_CR27","unstructured":"EAU Guidelines Edn. presented at the EAU EAU Guidelines. Edn. presented at the EAU Congress, Madrid 2025. ISBN 978-94-92671-29-5"},{"issue":"4","key":"3384_CR28","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ajur.2023.06.001","volume":"10","author":"SD Pandolfo","year":"2023","unstructured":"Pandolfo SD, Cerrato C, Wu Z, Franco A, Del Giudice F, Sciarra A, Verze P, Lucarelli G, Imbimbo C, Perdon\u00e0 S, Cherullo EE, Porpiglia F, Derweesh IH, Autorino R (2023) A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors. Asian J Urol 10(4):390\u2013406 Epub 2023 Aug 1. PMID: 38024426; PMCID: PMC10659988","journal-title":"Asian J Urol"},{"key":"3384_CR29","doi-asserted-by":"publisher","unstructured":"Gavi F, Fettucciari D, Rossi F, Panio E, Assumma S, Sanesi D, Silvestri A, Pallotta G, Cavarra V, Carerj C, Bizzarri FP, Bracco M, Testori N, Montesi M, Francocci A, Schubert O, Abed S, Filomena GB, Russo P, Turri F, Ragonese M, Foschi N, Palermo G, Totaro A, Racioppi M, Bientinesi R, Sacco E, Sighinolfi MC, Rocco B (2025) Robot-assisted vs open partial nephrectomy: a propensity-matched analysis of perioperative outcomes and midterm oncologic safety. Int Urol Nephrol. Dec 27. https:\/\/doi.org\/10.1007\/s11255-025-04977-2. Epub ahead of print. Erratum in: Int Urol Nephrol. 2026 Jan 20. doi: 10.1007\/s11255-026-05016-4. PMID: 41455064","DOI":"10.1007\/s11255-025-04977-2"},{"key":"3384_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.urology.2022.07.009","volume":"169","author":"CJ Britton","year":"2022","unstructured":"Britton CJ, Sharma V, Lohse CM, Lieske JC, Nichols PE, Khanna A, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH, Potretzke AM (2022) Progression of Chronic Kidney Disease Following Radical and Partial Nephrectomy. Urology 169:125\u2013133 Epub 2022 Jul 22. PMID: 35878813","journal-title":"Urology"},{"issue":"8","key":"3384_CR31","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.ejso.2023.03.212","volume":"49","author":"X Hu","year":"2023","unstructured":"Hu X, Wang Y, Shao Y, Wu K, Tang Y, Ren S, Li X (2023) Radical versus partial nephrectomy for T1 non-clear cell renal cell carcinoma. Eur J Surg Oncol 49(8):1519\u20131523 Epub 2023 Mar 16. PMID: 36958950","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"3384_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajur.2019.11.004","volume":"8","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Long G, Shang H, Ding B, Sun G, Ouyang W, Liu M, Chen Y, Li H, Xu H, Ye Z (2021) Comparison of the oncological, perioperative and functional outcomes of partial nephrectomy versus radical nephrectomy for clinical T1b renal cell carcinoma: A systematic review and meta-analysis of retrospective studies. Asian J Urol 8(1):117\u2013125 Epub 2019 Dec 4. PMID: 33569278; PMCID: PMC7859367","journal-title":"Asian J Urol"},{"key":"3384_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.euros.2026.01.009","volume":"85","author":"G Musso","year":"2026","unstructured":"Musso G, Meagher MF, Dabbas M, Garofano G, Birouty N, Yuen KL, Baker B, Saitta C, Patil D, Saito K, Yasuda Y, Tanaka H, Montorsi F, Briganti A, Salonia A, Capitanio U, Larcher A, Rosiello G, Fujii Y, Master VA, Derweesh IH (2026) Histology-specific Prognostic Impact of Microscopic Positive Surgical Margins in Renal Cell Carcinoma: Implications for Postoperative Surveillance. Eur Urol Open Sci 85:41\u201348. https:\/\/doi.org\/10.1016\/j.euros.2026.01.009PMID: 41674780; PMCID: PMC12887165","journal-title":"Eur Urol Open Sci"},{"issue":"11","key":"3384_CR34","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.3390\/jcm14113908","volume":"14","author":"G Garofano","year":"2025","unstructured":"Garofano G, Saitta C, Musso G, Meagher MF, Capitanio U, Dabbas M, Birouty N, Karamcheti S, Kim B, Yuen KL, Larcher A, Baker B, Autorino R, Pandolfo SD, Montorsi F, Saita A, Lazzeri M, Lughezzani G, Casale P, Buffi NM, Derweesh IH (2025) Positive Surgical Margins in Clear Cell Renal Cell Carcinoma: Prognostic Impact and Implications for Risk Stratification and Adjuvant Therapy. J Clin Med 14(11):3908. https:\/\/doi.org\/10.3390\/jcm14113908PMID: 40507670; PMCID: PMC12156122","journal-title":"J Clin Med"}],"container-title":["Journal of Robotic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03384-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11701-026-03384-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03384-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:27:10Z","timestamp":1781648830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11701-026-03384-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3384"],"URL":"https:\/\/doi.org\/10.1007\/s11701-026-03384-8","relation":{},"ISSN":["1863-2491"],"issn-type":[{"value":"1863-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"22 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"446"}}